|
|
|
|
|
|
JOIN US
Monday, July 19
9-10 am Pacific / 12-1 pm Eastern
Zoom (Click here to download Zoom)
|
|
PRI and the Pioneer Institute invite you attend an informative webinar on the policy landscape on treatment value and access and how policy proposals that lean on the Institute for Clinical and Economic Review (ICER) could impact patients, equity, and innovation.
Increasingly, federal and state lawmakers and regulators are looking to ICER and drug value assessment frameworks to determine drug access and pricing decisions. But not every drug pricing policy solution deserves merit – especially those that could threaten treatment access for underserved populations, jeopardize innovation, and ignore the perspective of patients who will be impacted by these policies.
Join us on July 19 to hear scholars from PRI and Pioneer Institute, along with policy experts, advocates and special guests for a timely discussion on the policy landscape on treatment value and access and how policy proposals that lean on ICER could impact patients.
|
|
|
Speakers
- William “Bill” Smith, PhD, Visiting Fellow in Life Sciences, Pioneer Institute
- Wayne Winegarden, Senior Fellow in Business & Economics, Pacific Research Institute
- Gary Puckrein, PhD, President & CEO, National Minority Quality Forum
- Anna Hyde, Vice President of Advocacy & Access, Arthritis Foundation
- Gunnar Esiason, Director of Patient Outreach, Boomer Esiason Foundation
|
|
|
 |
|
|
|
|
|
|
